Poster Abstract Session:
134. Fungi and Parasites in Immunocompromised Patients
Friday, October 5, 2018: 12:30 PM-1:45 PM
Room: S Poster Hall

Tracks: Adult ID, Pediatric ID, Transplant ID


Presentations:
1128
Utility of Anaerobic and Fungal Blood Cultures in the Pediatric Oncologic Population
Madan Kumar, D.O.; Benjamin Hanisch, MD
Posters
  • Blood Culture Horizontal Poster.pdf (756.4 kB)
    • 1129
    Targeted Voriconazole Prophylaxis in Heart Transplantation Recipients
    Michael Lin, BS; Ignacio Echenique, MD; Michael Angarone, DO; Allen Anderson, MD; Valentina Stosor, MD, FIDSA
    1130
    Low Risk of Pneumocystis jiroveci Pneumonia in Patients with Waldenstrom’s Macroglobulinemia on Ibrutinib
    Amanda E. Kusztos, BS; Matthew P. Cheng, MD; Joshua N. Gustine, MPH; Toni E. Dubeau, NP; Ann E. Woolley, MD; Sarah P. Hammond, MD; Lindsey R. Baden, MD; Jorge J. Castillo, MD; Nicolas C. Issa, MD
    1131
    Characteristics and Risk Factors for Mortality in Hematologic Patients with Invasive Non-Aspergillus Mold Infections: A Single Center 7-Year Cohort Study
    Hyeon-Jeong Lee, M.D.; Dong-Gun Lee, M.D., Ph.D.; Sung-Yeon Cho, M.D.
    1132
    Pneumocystis infection in children: National trends and characteristics in the United States, 1997-2012
    Kengo Inagaki, MD; Chad Blackshear, MS; Charlotte V. Hobbs, MD
    Posters
  • Poster_IDWeek_2018.png (3.1 MB)
    • 1133
    Epidemiology of Invasive Fungal Infections in Lung Transplant Recipients: Harnessing Data Mining Tools to Build a Comprehensive Database
    Christina Yek, MD; Donglu Xie, MS; Nicolas Barros, MD; Terrence Liu, BS; Ashley Wallace, BS; Beverley Adams-Huet, MS; Robert W. Haley, MD, FSHEA; Ricardo La Hoz, MD, FACP, FAST
    1134
    Novel T2Candida Panel Assay Compared to Blood Cultures for Detection of Candidemia in Transplant and Non-Transplant Patients.
    Noman Hussain, MD; Zohra Chaudhry, MD; Hira Rizvi, MD; Odaliz Abreu-Lanfranco, MD; Mayur Ramesh, MD; Ramon Del Busto, MD; Zachary Osborn, MPH; George Alangaden, MD, FIDSA
    Posters
  • T2 IDSA POSTER Noman-converted.pdf (555.2 kB)
    • 1135
    Strongyloides stercolaris Serology in Transplant Patients: to test or not?
    Karla Rivera Rivera, MD; Tulsi Shah, MBBS; Julia Garcia-Diaz, MD, FIDSA; Jonathan Hand, MD
    Posters
  • Strongyloides stercolaris Serology in Transplant Patients to test or not PDF.pdf (1.2 MB)
    • 1136
    Universal Prophylaxis for Prevention of Invasive Aspergillus in Lung Transplant Recipients
    Alexis Guenette, DO; A Adrian Gonzalez, MD; Amir Emtiazjoo, MD
    Posters
  • IDSA abstract october 2018.pdf (461.3 kB)
    • 1137
    Implementation of Universal Screening for Strongyloidiasis Among Solid Organ and Hematopoietic Stem Cell Transplantation Candidates in a Non-endemic Area
    Angelica Kottkamp, MD; Sapna Mehta, MD
    Posters
  • Poster Strongy.pdf (1.0 MB)
    • 1138
    Retrospective Cohort Analysis of Amphotericin B Nephrotoxicity in Kidney Transplant Recipients
    Mariam Assi, MD; Dominic Engracia, B.S.; Idris Yakubu, Pharm.D.; Gaurav Gupta, MD; Nargiza Kurbanova, RN, BSN, BA; Oveimar De La Cruz, MD
    Posters
  • IDWeek_AMB_final.pdf (153.2 kB)
    • 1139
    Novel Formulation SUBA-itraconazole Prophylaxis in Patients with Hematological Malignancy or Undergoing Allogeneic Stem Cell Transplantation: Follow Up Survival Data.
    Julian Lindsay, BPharm(Hons), MClinPharm; Indy Sandaradura, MD; Kelly Wong, PhD; Chris Arthur, MBBS; William Stevenson, MBBS, PhD; Ian Kerridge, MBBS; Keith Fay, MBBS; Luke Coyle, MBBS; Matthew Greenwood, MBBS
    Posters
  • IDweek 2018 Novel Formulation SUBA_ itraconazole Prophylaxis in Hematological Malignancy or Undergoing Allogeneic Stem Cell Transplantation_ Follow Up Survival Data (2).pdf (731.9 kB)
    • 1140
    GATA2 mutations are frequently identified among patients with myeloid malignancies who develop invasive aspergillosis
    Tyler D. Bold, MD, PhD; Matthew P. Cheng, MD; Rahul S. Vedula, MD; Francisco M Marty, MD; R. Coleman Lindsley Jr., MD, PhD

    CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


    See more of: Poster Abstract Session
    << Previous Session | Next Session >>

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.